Effect of Mismatching for MHA UTA2-1 on Clinical Outcome After HLA-identical Sibling Donor Allo-SCT
Overview
Overview
Authors
Authors
Affiliations
Affiliations
Soon will be listed here.
Citing Articles
Applying genomics in heart transplantation.
Keating B, Pereira A, Snyder M, Piening B Transpl Int. 2018; 31(3):278-290.
PMID: 29363220 PMC: 5990370. DOI: 10.1111/tri.13119.
References
1.
Spierings E, Kim Y, Hendriks M, Borst E, Sergeant R, Canossi A
. Multicenter analyses demonstrate significant clinical effects of minor histocompatibility antigens on GvHD and GvL after HLA-matched related and unrelated hematopoietic stem cell transplantation. Biol Blood Marrow Transplant. 2013; 19(8):1244-53.
DOI: 10.1016/j.bbmt.2013.06.001.
View
2.
Oostvogels R, Minnema M, van Elk M, Spaapen R, te Raa G, Giovannone B
. Towards effective and safe immunotherapy after allogeneic stem cell transplantation: identification of hematopoietic-specific minor histocompatibility antigen UTA2-1. Leukemia. 2012; 27(3):642-9.
PMC: 3593180.
DOI: 10.1038/leu.2012.277.
View
3.
Perez-Garcia A, de la Camara R, Torres A, Gonzalez M, Jimenez A, Gallardo D
. Minor histocompatibility antigen HA-8 mismatch and clinical outcome after HLA-identical sibling donor allogeneic stem cell transplantation. Haematologica. 2005; 90(12):1723-4.
View
4.
Marijt W, Heemskerk M, Kloosterboer F, Goulmy E, Kester M, van der Hoorn M
. Hematopoiesis-restricted minor histocompatibility antigens HA-1- or HA-2-specific T cells can induce complete remissions of relapsed leukemia. Proc Natl Acad Sci U S A. 2003; 100(5):2742-7.
PMC: 151411.
DOI: 10.1073/pnas.0530192100.
View
5.
Spierings E, Goulmy E
. Expanding the immunotherapeutic potential of minor histocompatibility antigens. J Clin Invest. 2005; 115(12):3397-400.
PMC: 1297265.
DOI: 10.1172/JCI27094.
View